Table of Content - Radiopharmaceutical Market Size, Share,Trends Report 2032 | MRFR

Radiopharmaceutical Market Segmentation

Radiopharmaceutical Type Outlook (USD Billion, 2018-2030)

Diagnostic

Therapeutic

Radiopharmaceutical Application Outlook (USD Billion, 2018-2030)

Neurology

Cardiology

Oncology

Others

Radiopharmaceutical Regional Outlook (USD Billion, 2018-2030)

North America Outlook (USD Billion, 2018-2030)
- North America Radiopharmaceutical by Type
  - Diagnostic
  - Therapeutic
- North America Radiopharmaceutical by Application
  - Neurology
  - Cardiology
  - Oncology
  - Others
- US Outlook (USD Billion, 2018-2030)
- US Radiopharmaceutical by Type
  - Diagnostic
  - Therapeutic
- US Radiopharmaceutical by Application
  - Neurology
  - Cardiology
  - Oncology
  - Others
- Canada Outlook (USD Billion, 2018-2030)
- Canada Radiopharmaceutical by Type
  - Diagnostic
  - Therapeutic
- Canada Radiopharmaceutical by Application
  - Neurology
  - Cardiology
  - Oncology
  - Others

Europe Outlook (USD Billion, 2018-2030)
- Europe Radiopharmaceutical by Type
  - Diagnostic
  - Therapeutic
- Europe Radiopharmaceutical by Application
  - Neurology
  - Cardiology
  - Oncology
  - Others
- Germany Outlook (USD Billion, 2018-2030)
- Germany Radiopharmaceutical by Type
  - Diagnostic
  - Therapeutic
- Germany Radiopharmaceutical by Application
  - Neurology
  - Cardiology
  - Oncology
  - Others
- France Outlook (USD Billion, 2018-2030)
- France Radiopharmaceutical by Type
  - Diagnostic
  - Therapeutic
- France Radiopharmaceutical by Application
  - Neurology
  - Cardiology
  - Oncology
  - Others
- UK Outlook (USD Billion, 2018-2030)
- UK Radiopharmaceutical by Type
  - Diagnostic
  - Therapeutic
- UK Radiopharmaceutical by Application
  - Neurology
  - Cardiology
  - Oncology
  - Others
- Italy Outlook (USD Billion, 2018-2030)
- Italy Radiopharmaceutical by Type
  - Diagnostic
  - Therapeutic
- Italy Radiopharmaceutical by Application
  - Neurology
  - Cardiology
  - Oncology
  - Others
- Spain Outlook (USD Billion, 2018-2030)
- Spain Radiopharmaceutical by Type
  - Diagnostic
  - Therapeutic
- Spain Radiopharmaceutical by Application
  - Neurology
  - Cardiology
  - Oncology
  - Others
- Rest Of Europe Outlook (USD Billion, 2018-2030)
- Rest Of Europe Radiopharmaceutical by Type
  - Diagnostic
  - Therapeutic
- Rest Of Europe Radiopharmaceutical by Application
  - Neurology
  - Cardiology
  - Oncology
  - Others

Asia-Pacific Outlook (USD Billion, 2018-2030)
- Asia-Pacific Radiopharmaceutical by Type
  - Diagnostic
  - Therapeutic
- Asia-Pacific Radiopharmaceutical by Application
  - Neurology
  - Cardiology
  - Oncology
  - Others
- China Outlook (USD Billion, 2018-2030)
- China Radiopharmaceutical by Type
  - Diagnostic
  - Therapeutic
- China Radiopharmaceutical by Application
  - Neurology
  - Cardiology
  - Oncology
  - Others
- Japan Outlook (USD Billion, 2018-2030)
- Japan Radiopharmaceutical by Type
  - Diagnostic
  - Therapeutic
- Japan Radiopharmaceutical by Application
  - Neurology
  - Cardiology
  - Oncology
  - Others
- India Outlook (USD Billion, 2018-2030)
- India Radiopharmaceutical by Type
  - Diagnostic
  - Therapeutic
- India Radiopharmaceutical by Application
  - Neurology
  - Cardiology
  - Oncology
  - Others
- Australia Outlook (USD Billion, 2018-2030)
- Australia Radiopharmaceutical by Type
  - Diagnostic
  - Therapeutic
- Australia Radiopharmaceutical by Application
  - Neurology
  - Cardiology
  - Oncology
  - Others
- Rest of Asia-Pacific Outlook (USD Billion, 2018-2030)
- Rest of Asia-Pacific Radiopharmaceutical by Type
  - Diagnostic
  - Therapeutic
- Rest of Asia-Pacific Radiopharmaceutical by Application
  - Neurology
  - Cardiology
  - Oncology
  - Others

Rest of the World Outlook (USD Billion, 2018-2030)
- Rest of the World Radiopharmaceutical by Type
  - Diagnostic
  - Therapeutic
- Rest of the World Radiopharmaceutical by Application
  - Neurology
  - Cardiology
  - Oncology
  - Others
- Middle East Outlook (USD Billion, 2018-2030)
- Middle East Radiopharmaceutical by Type
  - Diagnostic
  - Therapeutic
- Middle East Radiopharmaceutical by Application
  - Neurology
  - Cardiology
  - Oncology
  - Others
- Africa Outlook (USD Billion, 2018-2030)
- Africa Radiopharmaceutical by Type
  - Diagnostic
  - Therapeutic
- Africa Radiopharmaceutical by Application
  - Neurology
  - Cardiology
  - Oncology
  - Others
- Latin America Outlook (USD Billion, 2018-2030)
- Latin America Radiopharmaceutical by Type
  - Diagnostic
  - Therapeutic
- Latin America Radiopharmaceutical by Application
  - Neurology
  - Cardiology
  - Oncology
  - Others

Research Methodology on the Radio Pharmaceutical Market

Research Design:

The research approach for this study is to employ both qualitative and quantitative perspectives. The qualitative aspects involve the understanding of the need for and the different factors that are likely to have an impact on the radiopharmaceutical market. The quantitative evaluation is done by conducting a market survey, which includes primary and secondary data collection.

Research Objectives:

The prime objective of this research was to gain insight into the current state of the radio pharmaceutical market and to forecast the market size over the forecast period 2023 to 2030. It also sheds light on various technological advances and the impacts these advances are likely to have on the radio pharmaceutical industry.

Secondary Research:

A detailed study is conducted on secondary information sources including, books, newspapers, magazines, and industry reports; the objective of this study is to gain an overview of the market and a set of reliable data points to back up the figures that were gathered. This is done by referring to various industry databases, such as IBISWorld, Euromonitor, and Market Research Future. Histories of national, regional and global statistics on different factors such as historical market trends, evolving industry dynamics, demand drivers, and competitive landscape have been kept in mind while designing the report.

Primary Research:

A detailed survey is conducted with industry leaders such as manufacturers, stakeholders and industry experts to gain an in-depth understanding of the market trends, competition level and demand drivers. The survey covered several aspects such as industrial developments, overall process flow, product and design developments, supply and demand dynamics, cost structure, development trends and performance of the overall market.

Sampling Methodology:

The target population for the survey is a panel of 150 respondents ranging from radio pharmaceuticals suppliers and distributors, medical professionals and consultants. Convenience sampling is used to select the sample. The sample size of the survey is estimated using the Nicholls formula. Additionally, snowball sampling is used to uncover additional information from industry experts in order to get the most accurate picture of the current state of the market and the outlook for years to come.

Data Collection and Analysis Method:

The primary data collection is done by conducting both in-person questionnaires and online surveys. The data collected is analyzed using both qualitative and quantitative analysis. The data is further analyzed and validated by conducting multiple rounds of in-depth interviews with industry experts. Moreover, content analysis and factor analysis are used to gain insight into industry trends and developments and to identify influential factors in the market. The collected data is evaluated according to the research objectives and is used to draw insights about the market’s growth over the forecast period 2023 to 2030.

Market Representation:

The data for the report is presented in the form of tables and charts. The report contains a detailed market analysis, based on the value, volume, and CAGR growth of each segment identified. Historical data, current trends, and expected growth are studied and presented in the report.

Leading companies partner with us for data-driven Insights

Please fill in Business Email for Quick Response

We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.

1 EXECUTIVE SUMMARY

1 OVERVIEW 23

1.1.1 MARKET SYPNOSIS 23

2 MARKET INTRODUCTION

2.1 SCOPE OF THE STUDY 24

2.2 RESEARCH OBJECTIVE 24

2.3 LIST OF ASSUMPTIONS 24

3 RESEARCH METHODOLOGY

3.1 OVERVIEW 26

3.2 DATA MINING 26

3.2.1 SECONDARY RESEARCH 27

3.2.2 PRIMARY RESEARCH 28

3.2.3 FORECASTING METHODS 29

3.3 RESEARCH METHODOLOGY FOR MARKET SIZE ESTIMATION 31

3.3.1 BOTTOM-UP APPROACH 31

3.3.2 TOP-DOWN APPROACH 32

3.4 DATA TRIANGULATION 33

3.5 VALIDATION 33

4 MARKET DYNAMICS

4.1 OVERVIEW 34

4.2 DRIVERS 35

4.2.1 GROWING APPLICATION OF RADIOISOTOPES IN THE HEALTHCARE INDUSTRY 35

4.2.2 INCREASING USE OF RADIOPHARMACEUTICALS FOR THE DIAGNOSIS & TREATMENT OF CHRONIC DISEASES 35

4.2.3 TECHNOLOGICAL ADVANCEMENTS IN THE DIAGNOSTICS SECTOR 36

4.3 RESTRAINTS 37

4.3.1 SHORT HALF-LIFE OF RADIOPHARMACEUTICALS 37

4.3.2 HIGH COST OF RADIOPHARMACEUTICALS 37

4.4 OPPORTUNITY 38

4.4.1 TECHNOLOGICAL ADVANCEMENTS IN RADIOPHARMACEUTICAL OR MEDICINAL RADIO COMPOUNDS 38

5 MARKET FACTOR ANALYSIS

5.1 GLOBAL RADIOPHARMACEUTICALS MARKET: SUPPLY CHAIN ANALYSIS 39

5.1.1 NUCLEAR RESEARCH REACTORS (NRRS) 39

5.1.2 PROCESSORS 40

5.1.3 GENERATOR MANUFACTURERS 41

5.1.4 NUCLEAR PHARMACIES 41

5.1.5 PATIENTS AND HEALTH CARE PROVIDERS 41

5.2 PORTER’S FIVE FORCES MODEL 42

5.2.1 THREAT OF NEW ENTRANTS 43

5.2.2 BARGAINING POWER OF SUPPLIERS 43

5.2.3 BARGAINING POWER OF BUYERS 43

5.2.4 THREAT OF SUBSTITUTES 44

5.2.5 INTENSITY OF RIVALRY 44

6 RADIOPHARMACEUTICALS MARKET, BY TYPE

6.1 OVERVIEW 45

6.2 DIAGNOSTICS 46

6.3 THERAPEUTIC 48

7 RADIOPHARMACEUTICALS MARKET, BY APPLICATION

7.1 OVERVIEW 49

7.2 NEUROLOGY 50

7.3 CARDIOLOGY 51

7.4 ONCOLOGY 52

7.5 OTHERS 52

8 GLOBAL RADIOPHARMACEUTICALS MARKET, BY REGION

8.1 OVERVIEW 53

8.2 AMERICAS 54